First Trust Advisors’s Climb Bio CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$490K Buy
+42,677
New +$595K ﹤0.01% 2435

Other funds holding CLYM

First Trust Advisors's CLYM Position: Q3 2026 in Review

First Trust Advisors opened a new position in Climb Bio (CLYM) in Q3 2026: 42,677 shares worth $490K. The stake represents ﹤0.01% of the portfolio and ranks #2435 among its holdings.

128 funds tracked by Wall St. Rank hold CLYM as of Q3 2026.

  • First Trust Advisors held 42,677 shares of Climb Bio worth $490K as of Q3 2026.
  • Climb Bio was a new First Trust Advisors position in Q3 2026.
  • Climb Bio made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2435 holding.
  • 128 funds tracked by Wall St. Rank held Climb Bio as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.